Sandrine Susini

5PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1.

|Dec 12, 2024
Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology.

Romane Martineau, Sandrine Susini, Aurelien Marabelle

|Jan 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.

François-Xavier Danlos, Matthieu Texier, Bastien Job

|Jan 09, 2021
Interventional Radiology for Local Immunotherapy in Oncology.

Lambros Tselikas, Stephane Champiat, Rahul A Sheth

|Dec 06, 2018
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter.

Roberto Ferrara, Sandrine Susini, Aurelien Marabelle

Pageof 1

Frequent Collaborators

4 joint publications

Aurélien Marabelle

3 joint publications

Severine Mouraud

2 joint publications

Lambros Tselikas

2 joint publications

Stephane Champiat